Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone + Ropivacaine for Analgesia after TKA
NCT06205199Completed
- Sponsor
- The Second Hospital of Jilin University
- Start
- Oct 2022
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of hydromorphone in postoperative pain (2 arms), sponsored by The Second Hospital of Jilin University. Primary endpoints: Incidence of moderate to severe pain at rest at 24 hours and Incidence of moderate to severe pain with movement at 24 hours. Started Oct 2022; status: completed.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06205199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205199.